The joint association of the combined triglyceride-glucose index and atherogenic index of plasma with hypertension on stroke risk across different glycemic status: a prospective cohort study

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

TyG-AIP is associated with increased stroke risk, particularly in dysglycemic individuals, and exhibits joint effects with hypertension. The integration of TyG-AIP assessment with hypertension status enhances risk stratification, supporting comprehensive management of both metabolic and hemodynamic factors in stroke prevention.

Study context

Population
Participants with dysglycemia or normoglycemia, followed for stroke460 incident strokes
Participants
5,786 participants
Exposure
Higher vs lower TyG-AIP, alone and jointly with hypertension
  • PDMn = 3,490
  • NDMn = 2,296
Outcome
Incident stroke
Follow-up
8 years
Methodological detailsK-means clustering of TyG-AIP trajectories, multivariable Cox proportional hazards models
  • K-means clustering of TyG-AIP trajectories
  • Multivariable Cox proportional hazards models

Main finding

As reported in the abstract

Stroke risk per SD increase in TyG-AIP · 8 years

HR per SD increase in TyG-AIP, all participants

HR = 1.35, 95% CI 1.21-1.51

P < 0.001

HR in those with dysglycemia

HR = 1.54, 95% CI 1.21-1.95

P < 0.001

Observational data: associations, not effects.

Further findings

Nonlinear association of TyG-AIP with stroke

P for nonlinearity
0.002

Joint high TyG-AIP and hypertension

Synergistic interaction; both high TyG-AIP and hypertension had greatest risk, HR
2.89 (2.22-3.76) (95% CI)

"High-and-declining" TyG-AIP trajectory, PDM

Highest stroke risk, HR (95% CI); P
2.26 (1.62-3.15); P < 0.001

Discrimination (ROC)

AUC, TyG-AIP + hypertension
0.643
AUC, hypertension alone
0.571

Original publication

The joint association of the combined triglyceride-glucose index and atherogenic index of plasma with hypertension on stroke risk across different glycemic status: a prospective cohort study. Cardiovasc Diabetol. Published 26 March 2026. doi:10.1186/s12933-026-03080-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.